In ovarian cancer, downregulation of claudin-3/-4 promotes tumor growth and metastasis, while less expression of claudin-3/-4 along with claudin-7 results in high malignancy in breast cancer (Prat et al., 2010). Here, CLDN3 is linked to ovarian carcinoma.